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Nuclear bodyHTLV-I bZIP factor (HBZ) contains a C-terminal zipper domain involved in its interaction with c-Jun. This
interaction leads to a reduction of c-Jun DNA-binding activity and prevents the protein from activating
transcription of AP-1-dependent promoters. However, it remained unclear whether the negative effect of
HBZ-SP1 was due to its weak DNA-binding activity or to its capacity to target cellular factors to
transcriptionally-inactive nuclear bodies. To answer this question, we produced a mutant in which speciﬁc
residues present in the modulatory and DNA-binding domain of HBZ-SP1 were substituted for the
corresponding c-Fos amino acids to improve the DNA-binding activity of the c-Jun/HBZ-SP1 heterodimer.
The stability of the mutant, its interaction with c-Jun, DNA-binding activity of the resulting heterodimer, and
its effect on the c-Jun activity were tested. In conclusion, we demonstrate that the repression of c-Jun activity
in vivo is mainly due to the HBZ-SP1-mediated sequestration of c-Jun to the HBZ-NBs.
© 2009 Elsevier Inc. All rights reserved.IntroductionHuman T-cell leukemia virus type I (HTLV-I) is an oncoretrovirus
involved in the development of an often fatal form of leukemia termed
adult T-cell leukemia (ATL) (Uchiyama et al., 1977). Moreover, HTLV-I
is the etiologic agent of a neurological demyelinating disease known as
tropical spastic paraparesis/HTLV-I-associatedmyelopathy (Gessain et
al., 1985; Osame et al., 1986). Among the proteins encoded by the viral
genome, the Tax protein plays a key role in HTLV-I-induced ATL by
stimulating the proliferation and the transformation of HTLV-I-
infected T cells (Barbeau and Mesnard, 2007; Matsuoka and Jeang,
2007). Tax is also involved in the stimulation of viral proteingie, Centre d'études d'agents
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ll rights reserved.production by trans-activating proviral transcription. Tax interacts
with different members of the activating transcription factor/cAMP
response element-binding (ATF/CREB) protein family of basic leucine
zipper (bZIP) transcription factors and recruits transcriptional cofac-
tors such as p300 and CREB-binding protein (CBP), forming a
nucleoprotein complex on the viral promoter located in the 5′ long
terminal repeat (LTR) (Gachon et al., 2001, 2002; Kashanchi and Brady,
2005; Lemasson et al., 2002).
The 3′ LTR also contains a functional promoter (Landry et al., 2009;
Yoshida et al., 2008) controlling antisense transcription (Cavanagh et
al., 2006; Larocca et al., 1989; Murata et al., 2006). Various spliced and
unspliced transcripts initiate from the 3′ LTR (Yoshida et al., 2008)
allowing the synthesis of two protein isoforms of HBZ (Cavanagh et al.,
2006; Murata et al., 2006). However, the most abundant transcripts
detected in ATL cell lines and in cells isolated from infected patients
correspond to the spliced variant (Cavanagh et al., 2006; Usui et al.,
2008). The HBZ isoforms share about 95% amino acid sequence
identity and differ only at their N-terminal end (Cavanagh et al., 2006;
Murata et al., 2006): 7 amino acids speciﬁc for the unspliced HBZ
isoform and 4 amino acids speciﬁc for the spliced transcript derived
HBZ isoform termed here HBZ-SP1. Both isoforms act as repressors of
HTLV-I transcription although Tax-mediated transcriptional activation
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that by HBZ, this difference being due to a higher stability of the HBZ-
SP1 isoform (Yoshida et al., 2008). HBZ-SP1 down-regulates viral
transcription by interacting with nuclear Tax partners such as ATF/
CREB proteins, p300, and CBP (Clerc et al., 2008; Lemasson et al.,
2007). Consequently, Tax can no longer recruit p300/CBP on the viral
promoter and is then unable to trans-activate HTLV-I transcription. By
using HTLV-I viruses producing defective HBZ, it has been shown that
HBZ is necessary to enhance HTLV-I infectivity and persistence in
infected rabbits (Arnold et al., 2006), an observation which might be
consequential to the down-regulating ability of the HBZ isoforms on
Tax-dependent transcription (Mesnard et al., 2006).
The presence of HBZ has also been suggested to promote T-
lymphocyte proliferation (Arnold et al., 2008; Satou et al., 2006).
Interestingly, the HBZ isoforms are able to modulate activator protein-
1 (AP-1) activity and particularly interact with c-Jun (Basbous et al.,
2003a; Hivin et al., 2007; Matsumoto et al., 2005). The formation of
such a heterodimer prevents c-Jun from activating transcription of AP-
1-dependent promoters and leads to a reduction in its DNA-binding
activity (Basbous et al., 2003a; Hivin et al., 2006; Matsumoto et al.,
2005). It has been proposed that this inhibition of the c-Jun DNA-
binding activity by HBZ-SP1 could be responsible for the HBZ-SP1
repressor activity on c-Jun. However, we have recently demonstrated
that HBZ-SP1 can mediate the sequestration of JunB, another Jun
family member, to particular nuclear bodies (that we have termed
HBZ-NBs) corresponding to transcriptionally-inactive sites (Hivin et
al., 2007). In the light of this new data, it was important to determine
if the negative effect of HBZ-SP1 on c-Jun activity was due to the weak
DNA-binding activity of the HBZ-SP1/c-Jun heterodimer or to its
sequestration to HBZ-NBs. To answer this question, we generated a
mutant for which speciﬁc residues present in the modulatory (MD)
and DNA-binding domain (DBD) of HBZ-SP1 were substituted for the
corresponding c-Fos amino acids and its effect was tested on c-Jun
activity. By this approach, we demonstrate that the repression of c-Jun
activity in vivo is a consequence of the HBZ-SP1-mediated sequestra-
tion of c-Jun to the HBZ-NBs.
Results
Construct and analysis of the mutant HBZ-SP1-mutMD/DBD
HBZ-SP1 is a prototypical bZIP transcriptional factor (Fig. 1), with
an N-terminal transcriptional activation domain, a central domain
involved in its nuclear localization, and a C-terminal bZIP domainFig. 1. Structure of HBZ-SP1-mutMD/DBD. HBZ-SP1 possesses an activation domain (AD), a
(DBD) and a leucine zipper (ZIP). The wild type HBZ-SP1 (HBZ-SP1-WT), the mutated HB
aligned. MD sequences are underlined; DBD and the ﬁrst ZIP residues are in boxes. The conse
indicate HBZ-SP1-residues mutated to corresponding c-Fos amino acids.(Clerc et al., 2008; Gaudray et al., 2002; Hivin et al., 2005). However,
HBZ-SP1 DBD diverges from the consensus basic subdomain bb-bN–
AA-b(C/S)R-bb present in the bZIP domain of certain cellular
transcriptional factors (Johnson, 1993; Kouzarides and Ziff, 1988;
Vinson et al., 1989). In addition, we have recently demonstrated that
HBZ-SP1 contains a cluster of amino acids, termed MD (Fig. 1),
composed of basic and acidic residues immediately adjacent to DBD
and involved in the modulation of Jun transcriptional potency (Hivin
et al., 2006). We had then concluded that both HBZ-SP1 domains, MD
and DBD, were responsible for the HBZ-SP1-mediated inhibition of c-
Jun activity. If this conclusion is correct, we should be able to
transform HBZ-SP1 into a transcriptional activator of c-Jun by
mutating its MD and DBD regions. In order to test this idea, speciﬁc
residues present in the HBZ-SP1 MD and DBD domains were
substituted for the corresponding c-Fos amino acids. Indeed, unlike
HBZ-SP1, c-Fos, a typical heterodimer partner of c-Jun, has been
demonstrated to stimulate the trans-activating potential of c-Jun
through its MD and DBD regions (Neuberg et al., 1991; Ryseck and
Bravo, 1991). The structure of the new mutant, named here HBZ-SP1-
mutMD/DBD, is shown in Fig. 1. Because N, A, and R have been
described to be highly conserved (N–AA-b(C/S)R) in cellular bZIP
factor DBD (Fig. 1), these residues were ﬁrst reintroduced in the HBZ-
SP1 basic motif (A–AK-HSA replaced with N–AA-KSR). However, we
have previously demonstrated that these mutations are not sufﬁcient
(Hivin et al., 2006). For this reason, additional substitutions were
generated in the HBZ-SP1 basic motif as already described (Hivin et
al., 2006) to create an efﬁcient DBD (as shown in Fig. 1). MD was also
modiﬁed since c-Fos has been demonstrated to stimulate the trans-
activating potential of c-Jun through not only its DBD but also its MD
(Neuberg et al., 1991; Ryseck and Bravo, 1991).
First, in vivo expression of HBZ-SP1-mutMD/DBDwas compared to
the wild type HBZ-SP1 (HBZ-SP1-WT) by cloning their cDNA into a
mammalian expression vector derived from pIRES2-EGFP (Clontech).
This vector gives rise to proteins under study (here HBZ-SP1-WT and
HBZ-SP1-mutMD/DBD) and enhanced-green-ﬂuorescent protein
(EGFP) from the same bicistronic mRNA. EGFP serves as an internal
standard for normalization and allows the comparison of the level of
expression for both HBZ-SP1 forms. Moreover, our vector permits Myc
tagging of HBZ-SP1 proteins at the N-terminus. Protein levels were
determined by immunoblotting and, as shown in Fig. 2A, the mutant
was stably expressed. We then analyzed the ability of HBZ-SP1-
mutMD/DBD to interact with c-Jun by a yeast two-hybrid assay. By
this approach, we found that the mutations introduced in HBZ-SP1
MD and DBD sequences did not alter the interactions with c-Jun (Fig.modulatory domain (MD), and a bZIP structure, which includes a DNA-binding domain
Z-SP1 (HBZ-SP1-mutMD/DBD), and c-Fos modulatory and DNA-binding domains are
rved residues of the consensus basic motif (bb-bN–AA-b(C/S)R-bb) are in bold. Arrows
Fig. 2. DNA-binding and trans-activation potential of c-Jun/HBZ-SP1-mutMD/DBD complex. (A) Expression of HBZ-SP1-WT and HBZ-SP1-mutMD/DBD in vivo. Expression of the
proteins in 293Tcells was detected bywestern blotting using total cell extracts. HBZ-SP1 proteins and EGFPwere visualized using the 9E10 anti-Mycmonoclonal antibody and an anti-
EGFP antiserum, respectively (- : cells transfected with the empty pIRES2-EGFP-Myc plasmid). Molecular size markers are indicated in kiloDaltons (kDa) on the left. (B) Interaction
study between HBZ-SP1-mutMD/DBD and c-Jun by yeast two-hybrid assays using a liquid culture β-galactosidase assay. Yeasts were transformed with the expression vector pGAD
containing the entire coding sequence of c-Jun fused to the GAL4 activation domain along with pGBT9 expressing the GAL4 DNA-binding domain fused to the region encompassing
residues 120 to 206 from c-Fos, HBZ-SP1, or themutant. Theβ-galactosidase activitywasmeasured for three independent colonies per transformation assay using ONPG as a substrate.
Mean values presented in the graph are expressed inMiller units. (C) HBZ-SP1-mutMD/DBD interacts with c-Jun in vivo. 293Tcells were transfectedwith expression vectors pcDNA-c-
Jun in the presence of empty pcDNA3.1(−)/Myc-His or pcDNA3.1(−)/Myc-His encoding Myc-tagged HBZ-SP1-mutMD/DBD or the wild type HBZ-SP1. (- : cells transfected with the
empty pcDNA3.1(−)/Myc-His). Proteins from total lysates were directly probed with rabbit anti-c-Jun (Western blot shown above) or immunoprecipitated with mouse anti-Myc tag
antibody, followed by Western analysis with rabbit anti-c-Jun (Western blot below). (D) DNA-binding activity of HBZ-SP1-mutMD/DBD. Microwells containing the AP-1-binding
probe were incubated with nuclear extracts of 293T cells cotransfected with 4 μg of pcDNA-c-Jun and 4 μg of the vector expressing c-Fos, HBZ-SP1-WT, or HBZ-SP1-mutMD/DBD.
Negative and positive controls corresponded to cells transfectedwith the pcDNAemptyvector andpcDNA-c-Jun alone, respectively. The data represent themeans of three values±S.D.
In the panel above, immunoblotting of nuclear proteins from transfected 293T cells was conducted using anti-c-Jun antibodies.
Fig. 3. HBZ-SP1-mutMD/DBD inhibits the trans-activation potential of c-Jun. CEM
cells were cotransfected with 2 μg of a vector containing the luciferase reporter gene
driven by the collagenase promoter, 5 μg of pcDNA3.1-lacZ, 1 μg of pcDNA-c-Jun, and
2 μg of pcDNA3.1(−)/Myc-His expressing HBZ-SP1-WT or HBZ-SP1-mutMD/DBD.
Luciferase values are expressed as fold increases relative to values measured in cells
transfected with pcDNA3.1(−)/Myc-His in the presence of the luciferase reporter
vector. The total amount of DNA in each series of transfection was kept constant by
the addition of the needed quantity of empty plasmids. Luciferase values were
normalized for β-galactosidase activity. Values represent the mean±S.D. (n=3).
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DBD was also studied by cotransfecting 293T cells with the expression
vectors pcDNA-c-Jun and pcDNA3.1(−)/Myc-His encoding HBZ-SP1-
WT or HBZ-SP1-mutMD/DBD. This vector permits Myc tagging of the
viral proteins at the C-terminus. Cell extracts were then immunopre-
cipitated with anti-Myc tag monoclonal antibody, followed by
Western analysis using rabbit anti-c-Jun antiserum. As shown in Fig.
2C, we found that c-Jun was immunoprecipitated with HBZ-SP1-
mutMD/DBD and HBZ-SP1-WT conﬁrming that the mutant is capable
of interacting with c-Jun in vivo.
We also studied the DNA-binding activity of c-Jun in the presence
of HBZ-SP1-mutMD/DBD. To evaluate DNA binding, we used the
microwell colorimetric assay from Active Motif Europe (Renard et al.,
2001), which is a highly sensitive non-radioactive DNA-binding
ELISA. We had previously used this approach for the study of
complex formation between c-Jun, HBZ-SP1, and the AP-1 motif
(Basbous et al., 2003a; Hivin et al., 2006). Brieﬂy, nuclear extracts of
293T cells transfected with c-Jun and either c-Fos, HBZ-SP1-WT, or
HBZ-SP1-mutMD/DBD expression vectors were incubated in the
presence of a double-stranded oligonucleotide containing the AP-1
site immobilized on a microwell plate. The DNA-binding activity was
then measured by colorimetric assay using mouse anti-c-Jun
antibodies. The ability of c-Jun to bind to the AP-1 motif was
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showed a signiﬁcant afﬁnity for the AP-1 binding motif in the
presence of HBZ-SP1-mutMD/DBD (Fig. 2D). This result was
expected since amino acid substitutions were introduced in the
sequence of the DBD basic subdomain of HBZ-SP1.
HBZ-SP1-mutMD/DBD still inhibits c-Jun transcriptional activity
We next examined the effect of HBZ-SP1-mutMD/DBD on
transcription driven by the collagenase promoter that contains a
canonical AP-1 element. The reporter plasmid was cotransfected in
CEM cells with pcDNA-c-Jun in the presence of the mammalian
expression vector pcDNA3.1(−)/Myc-His encoding HBZ-SP1-WT or
HBZ-SP1-mutMD/DBD. As shown in Fig. 3, expression of c-Jun alone
activated expression of the luciferase reporter gene by 21-fold, butFig. 4. Subnuclear localization of HBZ-SP1-mutMD/DBD in COS cells. (A) HBZ-SP1 mutMD/
DBD, and c-Jun were transiently transfected into COS cells. Cells were cultivated on glass sid
nucleus by confocal microscopy. The localization of theMyc-tagged chimeras was analyzed us
Jun was detected using a rabbit anti-c-Jun antibody and goat anti-rabbit IgG antibody co
cotransfected with expression vectors for c-Jun in the presence of c-Fos, HBZ-SP1-WT, or HB
localization of c-Fos was analyzed using mouse anti-c-Fos antibody and goat anti-mouse IgG
were performed by confocal microscopy. The white bars correspond to a scale of 10 μm.this stimulation was inhibited not only in the presence of HBZ-SP1-
WT but also of HBZ-SP1-mutMD/DBD. These data suggested that the
modiﬁcation of HBZ-SP1 MD and DBD sequences by the correspond-
ing c-Fos domains was not sufﬁcient to counteract the negative effect
of HBZ-SP1 on c-Jun activity. However, as DBD has been shown to be
involved in the nuclear transport of the viral protein (Hivin et al.,
2005), the absence of a trans-activation potential by HBZ-SP1-
mutMD/DBD could be an aberrant subcellular localization of this
mutant. Its subcellular distribution was therefore studied by
immunoﬂuorescence microscopy using a mouse anti-Myc antibody
in COS cells transfected with the Myc-tagged HBZ-SP1-mutMD/DBD
expression vector pcDNA3.1(−)/Myc-His. As shown in Fig. 4A, HBZ-
SP1-mutMD/DBD did localize to the nucleus. Interestingly, the
mutant also accumulated in HBZ-NBs as we had previously described
for HBZ-SP1-WT (Hivin et al., 2005, 2007).DBD accumulates in HBZ-NBs. Expression vectors for HBZ-SP1-WT, HBZ-SP1-mutMD/
es, ﬁxed, and treated with Vectashield containing DAPI for direct characterization of the
ing themouse anti-Myc antibody and goat anti-mouse IgG antibodies coupled to FITC. c-
upled to Texas Red. (B) HBZ-SP1-mutMD/DBD colocalizes with c-Jun. COS cells were
Z-SP1-mutMD/DBD. The viral proteins and c-Jun were detected as described above. The
antibodies coupled to FITC. Analyses of the green, red, and merged ﬂuorescent signals
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We have recently demonstrated that HBZ-SP1-mediated seques-
tration of JunB to the HBZ-NBs might be causing the repression of
JunB activity in vivo (Hivin et al., 2007). Therefore, we conducted a
comparison between the staining pattern of c-Jun induced by HBZ-
SP1-WT and by HBZ-SP1-mutMD/DBD. In the presence of c-Fos, c-
Jun showed a diffuse signal in the nuclei of transfected COS cells
(Fig. 4B) while it was targeted to HBZ-NBs in the presence of HBZ-
SP1-WT (Fig. 4B). Interestingly, a similar distribution was observed
in the presence of HBZ-mutMD/DBD (Fig. 4B). Hence, our results
strongly argue that HBZ-SP1 inhibits c-Jun activity by sequestration
to HBZ-NBs as already described for JunB (Hivin et al., 2007).
Moreover, they suggest that the mutations in the HBZ-SP1 MD and
DBD sequence are not sufﬁcient to transform HBZ-SP1 into an
activator of c-Jun because HBZ-SP1-mutMD/DBD remains able to
target c-Jun into HBZ-NBs.Fig. 5.H14F does not form HBZ-NBs in the presence of c-Jun. (A) Comparison of the structures
Expression vectors for HBZ-SP1-mutMD/DBD or H14F were cotransfected with a c-Jun expre
collagenase promoter as described in the legend of Fig. 3. (C) Immunoﬂuorescence microsco
pcDNA-c-Jun and pcDNA-H14F-Myc were analyzed as described in the legend of Fig. 4. Anal
microscopy. The white bars correspond to a scale of 10 μm.We had previously constructed a HBZ-SP1/c-Fos chimera, termed
H14F (Hivin et al., 2006) that has a structure identical to HBZ-SP1-
mutMD/DBD except for its ZIP motif. Indeed, H14F possesses the ZIP
motif of c-Fos while HBZ-SP1-mutMD/DBD contains that of HBZ-SP1
(Fig. 5A). Interestingly, as shown in Fig. 5B, H14F stimulates c-Jun
transcriptional activity (Hivin et al., 2006). For this reason, the nuclear
distribution of c-Jun was studied in the presence of H14F. When H14F
and c-Jun were coexpressed in COS cells, H14F colocalized with c-Jun
and both proteins were diffusely distributed throughout the nucleus
(Fig. 5C). This observation supports the notion that the ZIP motif of
HBZ-SP1 is involved in the repression of c-Jun activity by targeting the
cellular factor into the HBZ-NBs.
It has been proposed that the HBZ isoform produced by the non-
spliced mRNA inhibits c-Jun activity by promoting c-Jun degradation
through a proteasome-dependent pathway (Matsumoto et al., 2005)
while HBZ-SP1 has been found to have less ability to degrade c-Jun
(Isono et al., 2008). Therefore we also studied the nuclearof HBZ-SP1-mutMD/DBD and H14F and (B) their effect on the trans-activation by c-Jun.
ssion vector together with a vector containing the luciferase reporter gene driven by the
py analysis of the colocalization of c-Jun and H14F in vivo. COS cells cotransfected with
yses of the green, red, and merged ﬂuorescent signals were performed by ﬂuorescence
Fig. 6. Confocal microscopy analysis of the colocalization of c-Jun and the HBZ isoform. COS cells cotransfected with pcDNA-c-Jun and pcDNA-HBZ-Myc were labelled as described in
the legend of the Fig. 4. Analysis of the green, red, and merged ﬂuorescent signals was performed by confocal microscopy. The white bars correspond to a scale of 10 μm.
200 I. Clerc et al. / Virology 391 (2009) 195–202distribution of c-Jun in the presence the HBZ isoform (Fig. 6). The
staining pattern of c-Jun was modiﬁed since the viral protein was
able to entail a redistribution of c-Jun into HBZ-speckled structures
already described by us and corresponding to transcriptionally-
inactive sites (Hivin et al., 2005).
Discussion
The AP-1 transcription complex is involved in a multitude of
cellular processes such as proliferation, differentiation, and cell
death. In unstimulated T cells, the basal AP-1 level is low but there
is a rapid induction of AP-1 activity after T-cell stimulation. The AP-
1 transcription complex has been shown to be involved in the
regulation of numerous cellular genes involved in lymphocyte
activation, such as the IL-2 gene (Foletta et al., 1998). Interestingly,
high levels of AP-1 activity has been detected in HTLV-I-infected T-
cell lines (Iwai et al., 2001; Mori et al., 2000), with increased levels
of mRNAs encoding c-Jun, JunB, JunD, c-Fos, and Fra-1 (Fujii et al.,
1991; Hooper et al., 1991). In addition, it has been suggested that
Tax could be involved in AP-1 activation through the phosphati-
dylinositol 3-kinase/Akt pathway (Peloponese and Jeang, 2006). On
the other hand, high constitutive activation of AP-1 has also been
described in primary non Tax-expressing primary ATL cells, in
which active AP-1 complexes contain JunD but not c-Jun and JunB
(Mori et al., 2000), suggesting that c-Jun and JunB are not active in
ATL cells.
Interestingly, non-spliced and spliced HBZ mRNAs (involved in
the production of the HBZ and HBZ-SP1 isoforms, respectively)
have been reported to be detectable in almost all tested ATL cells
(Murata et al., 2006; Satou et al., 2006; Usui et al., 2008). Both
isoforms are able to modulate AP-1 activation by binding to the
different members of the Jun family (Basbous et al., 2003a; Hivin et
al., 2006, 2007; Matsumoto et al., 2005). Furthermore, their
interaction with c-Jun and JunB leads to a reduction in their
transcriptional activity (Basbous et al., 2003a; Hivin et al., 2006,
2007; Matsumoto et al., 2005). We have previously demonstrated
that HBZ-SP1 inhibits JunB transcriptional activity by targeting JunB
to HBZ-NBs, which correspond to inactive sites of transcription
(Hivin et al., 2005, 2007). Herein, we conﬁrm that HBZ-SP1-
mediated sequestration of c-Jun to the HBZ-NBs may also be
causing the repression of c-Jun activity. Indeed, we generated amutant, HBZ-SP1-mutMD/DBD, for which speciﬁc residues present
in the MD and DBD of HBZ-SP1 were substituted for corresponding
amino acids of c-Fos. Although this mutant in the presence of c-Jun
showed a signiﬁcant in vitro afﬁnity for the AP-1 binding site, it
remained unable to stimulate transcription of the AP-1-dependent
promoter of the collagenase gene in vivo. On the other hand, when
the bZIP domain of this mutant was replaced by the corresponding
ZIP domain of c-Fos (HBZ-SP1-mutMD/DBD modiﬁed into H14F),
the heterodimer H14F/c-Jun bound to the AP-1 binding sequence
in vitro (Hivin et al., 2006) and was further capable of highly
activating AP-1-dependent promoter transcription in vivo. We have
previously observed that the ZIP domain of HBZ-SP1 is involved in
its nuclear trafﬁcking and that its association with JunB leads to the
formation of HBZ-NBs (Hivin et al., 2007). We show here that c-Jun
also forms HBZ-NBs in the presence of HBZ-SP1-mutMD/DBD while
this transcription factor is diffusely distributed throughout the
nucleus in the presence of H14F, which is identical to HBZ-SP1-
mutMD/DBD except for its ZIP domain. Moreover, we have already
demonstrated that in the presence of JunD, HBZ-SP1 is also
diffusely distributed throughout the nucleoplasm and that no
HBZ-NBs are formed in this situation (Hivin et al., 2007).
Interestingly, JunD is the only member of the Jun family that can
be activated by HBZ-SP1 (Kuhlmann et al., 2007). Taken together,
our results suggest that HBZ-SP1 inhibits c-Jun and JunB trans-
activating capacity in vivo mainly by their sequestration to the
HBZ-NBs.
The HBZ isoform produced by the non-spliced mRNA is also
capable of inhibiting c-Jun by promoting its proteasomal degrada-
tion (Matsumoto et al., 2005). It has been suggested that HBZ would
act as a tethering factor between the 26S proteasome and c-Jun
(Isono et al., 2008). On the other hand, HBZ-SP1 has less ability to
promote the degradation of c-Jun because its interaction with the
proteasome is less efﬁcient than that of HBZ (Isono et al., 2008).
This difference is not unexpected since the N-terminal region of HBZ
is involved in the regulation of c-Jun degradation (Matsumoto et al.,
2005). It remains unclear why both isoforms would inhibit c-Jun by
two different mechanisms. One possible explanation might be that
the HBZ-NBs correspond to transient storage sites to control
temporary c-Jun activity. HBZ-NBs containing HBZ would promote
c-Jun degradation while HBZ-SP1-containing NBs would rather serve
as passive storage sites for c-Jun. In the latter case, it is conceivable
201I. Clerc et al. / Virology 391 (2009) 195–202that the stored c-Jun could be eventually recruited to active
transcription loci according to the state of the infected T-cell. For
the moment, this model remains hypothetical and still needs further
experiments to be demonstrated.
Materials and methods
Plasmid constructs
The vectors pcDNA-HBZ-Myc, pcDNA-HBZ-SP1-Myc, pcDNA-
H14F-Myc, pcDNA-c-Jun, and pcDNA-c-Fos constructs have pre-
viously been described (Cavanagh et al., 2006; Hivin et al., 2006). To
generate HBZ-SP1-mutMD/DBD, DNA was ampliﬁed by PCR from
the previously published H14F chimera (Hivin et al., 2006) and
subcloned into pcDNA3.1(−)/Myc-His generating pcDNA-HBZ-SP1-
mutMD/DBD-ΔZIP. The HBZ-SP1 ZIP DNA was then ampliﬁed from
pcDNA-HBZ-SP1-Myc, digested with HindIII, and subcloned in frame
into HindIII-linearized pcDNA-HBZ-SP1mutMD/DBD-ΔZIP to pro-
duce pcDNA-HBZ-SP1-mutMD/DBD. The artiﬁcially introduced
HindIII site was then deleted to regenerate the proper HBZ-SP1
amino acid sequence. Site-directed mutagenesis was performed
using the QuikChange site-directed mutagenesis kit (Stratagene)
and the construct was sequenced to ensure that no unintended
mutations were introduced during PCR ampliﬁcation. The pIRES2-
EGFP-Myc plasmid was obtained from Jihane Basbous. The vector
allows detection of the recombinant protein with an anti-Myc
antibody. For the different constructs, ampliﬁed DNA was cloned
into EcoRI/BamHI-digested pIRES2-EGFP-Myc. For yeast two-hybrid
assays in yeast, ampliﬁed DNA was digested by EcoRI and cloned
into pGBT9.
Analysis of protein expression by western blotting
293T cells were cultured in DMEM supplemented with 10% FCS
and transfected with 7 μg of expression vector using the jetPEI™
transfection reagent (Qbiogene) according to the manufacturer's
instructions. Protein extracts (100 μg) from transfected 293T cells
were electrophoresed onto sodium dodecyl sulphate-polyacryla-
mide gel (SDS-PAGE) and blotted on polyvinylidene diﬂuoride
(PVDF) membranes (Millipore). Membranes were then incubated
1 h at room temperature in a blocking solution (phosphate-
buffered saline [PBS] containing 5% milk) prior to addition of
antiserum. After 1 h, membranes were washed three times with
PBS-0.5% Tween 20 and further incubated with a peroxydase-
conjugated goat anti-mouse IgG antibody for 1 h. After three
washes, membranes were incubated with the enhanced chemilu-
minescence (ECL) reagent (Amersham Pharmacia Biotech). Mem-
branes were then exposed to hyperﬁlms-ECL (Amersham
Pharmacia Biotech). Proteins with two Myc epitopes, tagged at
their N-terminal end, were detected with the mouse anti-Myc
antibody 9E10 (Sigma) while EGFP was revealed with a mouse
anti-EGFP antibody (Clontech). Mouse anti-EGFP and anti-c-Jun
antibodies were purchased from Clontech and Oncogene Research
Products, respectively.
Immunoprecipitation assays
Immunoprecipitations were performed as already described (Clerc
et al., 2008). Brieﬂy, 293T were transfected with 5 μg of expression
vector using the jetPEI™ transfection reagent (Qbiogene). Lysates
were prepared in radioimmunoprecipitation assay (RIPA) buffer
(50 mM Tris–HCl, pH 8.0, 1% Triton X-100, 100 mM NaCl, 1 mM
MgCl2, 2 mM benzamidine, 2 μg/ml of leupeptin, 2 μg/ml of aprotinin,
and 1 mM PMSF). Antibody-bound beads were washed in RIPA buffer
and 200 μg of cell lysates were added to each antibody-bead
suspension, incubated overnight, and washed several times in RIPAbuffer. Bound proteins were analyzed on SDS-polyacrylamide gel and
detected by Western blotting as described.
Microwell colorimetric AP-1 assays
Nuclear extracts (15 μg) of cotransfected 293Tcells were incubated
with 30 μl of binding buffer (10 mM HEPES pH 7.5, 8 mM NaCl, 12%
glycerol, 0.2 mM EDTA, 0.1% BSA) in microwells coated with probes
containing the AP-1-binding site (Trans-AM™ AP-1 of Active Motif
Europe, Belgium). After 1 h incubation at room temperature,
microwells were washed three times with PBS containing 0.1%
Tween 20. The AP-1-bound complexes were detected with a mouse
anti-c-Jun antibody followed by the addition of a peroxydase-
conjugated antibody. For colorimetric detection, tetramethylbenzi-
dine was incubated at room temperature before addition of the stop
solution. Optical density was read at 450 nm, using a 620 nm reference
wavelength with a Tecan microplate reader.
Yeast two-hybrid assays
Interactions between HBZ-SP1-mutMD/DBD and c-Jun were
analyzed by two-hybrid assay in the Saccharomyces cerevisiae strain
HF7c (Wurch et al., 1990). Strain HF7c possesses the Escherichia coli
lacZ gene driven by three copies of the GAL4 consensus sequence. The
region of the mutant containing both MD and bZIP domain (from
amino acid 120 to 206) was cloned in frame with the GAL4 DNA-
binding domain in the pGBT9 vector. Yeasts were cotransformed with
pGBT9 and pGAD-c-Jun as previously described (Basbous et al.,
2003b). The β-galactosidase assay was carried out in the presence of
o-nitrophenyl-β-D-galactopyranoside (ONPG) as a substrate on three
independent colonies per transformation according to the manufac-
turer's protocol (Clontech). The β-galactosidase activity was calcu-
lated in Miller units (Miller, 1972).
Cotransfections and luciferase assays
CEM cells were transiently cotransfected according to the
previously published protocol (Gachon et al., 2001). The β-galacto-
sidase-containing pcDNA3.1-lacZ vector (5 μg) was added in each
transfection to control for transfection efﬁciency. The total amount of
DNA in each transfection was kept constant through the addition of
appropriate quantities of empty plasmids. Equal amounts of proteins
from each cell extracts were then used for luciferase and β-
galactosidase assays. Luciferase assays were performed in an auto-
mated luminometer with the Genofax A kit (Yelen, Ensue la Redonne,
France) (Arpin-Andre and Mesnard, 2007).
Immunoﬂuorescence microscopy analysis
COS cells were cultured in DMEM supplemented with 10% FCS.
Cells were then seeded onto glass slides and, after 24 h, transfected
using the jetPEI™ transfection reagent (Qbiogene). At 48 h post-
transfection, cells were washed with PBS, ﬁxed, and permeabilized
with 4% paraformaldehyde and 0.1% Triton X-100 for 10 min at room
temperature. Cells were incubated with primary antibody (mouse
anti-Myc antibody 9E10, Sigma, or rabbit anti-c-Jun, Santa Cruz
Biotechnology Inc.) for 1 h at room temperature. The same approach
was carried out with COS cells transfected with pcDNA-c-Fos labelled
with mouse anti-c-Fos antibody from Santa Cruz Biotechnology.
Samples were subsequently washed with PBS and then incubated
with secondary FITC- or Texas Red-labelled antibodies (Pierce) for 1 h
at room temperature. Coverslips were mounted with the Vectashield
reagent containing DAPI (Abcys) for direct observation. Fluorescence
images were acquired by ﬂuorescence microscopy (model DM R;
Leica) at room temperature with a 63×, NA 1.32, oil immersion
objective at pinhole size 1 Airy (observation with immersion oil type
202 I. Clerc et al. / Virology 391 (2009) 195–202DF, Cargille Laboratories Inc.). DAPI, FITC, and Texas Red were excited
by 365-, 492-, and 596-nm laser light and emission was detected at
420, 520, and 620 nm, respectively. Analysis of the green, red, and
yellow ﬂuorescence for colocalization experiments was performed
with a Bio-Rad MRC 1024 confocal microscope.
Acknowledgments
This work was supported by institutional grants from the Centre
National de la Recherche Scientiﬁque (CNRS) and the Université
Montpellier I (UM I), and grants to J.M.M. from the Ligue Contre le
Cancer (Comité de l'Hérault) and the Association pour la Recherche
sur le Cancer (ARC no. 3606). I.C. is supported by a fellowship from the
Agence Nationale de Recherche sur le SIDA (ANRS).
References
Arnold, J., Yamamoto, B., Li, M., Phipps, A.J., Younis, I., Lairmore, M.D., Green, P.L., 2006.
Enhancement of infectivity and persistence in vivo by HBZ, a natural antisense
coded protein of HTLV-1. Blood 107, 3976–3982.
Arnold, J., Zimmerman, B., Li, M., Lairmore, M.D., Green, P.L., 2008. Human T-cell
leukemia virus type-1 antisense-encoded gene, Hbz, promotes T-lymphocyte
proliferation. Blood 112, 3788–3797.
Arpin-Andre, C., Mesnard, J.M., 2007. The PDZ domain-binding motif of the human Tcell
leukemia virus type 1 tax protein induces mislocalization of the tumor suppressor
hScrib in T cells. J. Biol. Chem. 282, 33132–33141.
Barbeau, B., Mesnard, J.M., 2007. Does the HBZ gene represent a new potential target for
the treatment of adult T-cell leukemia? Int. Rev. Immunol. 26, 283–304.
Basbous, J., Arpin, C., Gaudray, G., Piechaczyk, M., Devaux, C., Mesnard, J.M., 2003a. HBZ
factor of HTLV-I dimerizes with transcription factors JunB and c-Jun and modulates
their transcriptional activity. J. Biol. Chem. 278, 43620–43627.
Basbous, J., Bazarbachi, A., Granier, C., Devaux, C., Mesnard, J.M., 2003b. The central
region of human T-cell leukemia virus type 1 Tax protein contains distinct domains
involved in subunit dimerization. J. Virol. 77, 13028–13035.
Cavanagh, M.-H., Landry, S., Audet, B., Arpin-Andre, C., Hivin, P., Paré, M.-E., Thete, J.,
Wattel, E., Marriott, S.J., Mesnard, J.-M., Barbeau, B., 2006. HTLV-I antisense
transcripts initiating in the 3′LTR are alternatively spliced and polyadenylated.
Retrovirology 3, 15.
Clerc, I., Polakowski, N., Andre-Arpin, C., Cook, P., Barbeau, B., Mesnard, J.-M., Lemasson,
I., 2008. An interaction between the human T cell leukemia virus type 1 basic
leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to the
down-regulation of tax-dependent viral transcription by HBZ. J. Biol. Chem. 283,
23903–23913.
Foletta, V.C., Segal, D.H., Cohen, D.R., 1998. Transcriptional regulation in the immune
system: all roads lead to AP-1. J. Leukoc. Biol. 63 (2), 139–152.
Fujii, M., Niki, T., Mori, T., Matsuda, T., Matsui, M., Nomura, N., Seiki, M., 1991. HTLV-1 Tax
induces expression of various immediate early serum responsive genes. Oncogene
6, 1023–1029.
Gachon, F., Gaudray, G., Thebault, S., Basbous, J., Kofﬁ, A.J., Devaux, C., Mesnard, J.M.,
2001. The cAMP response element binding protein-2 (CREB-2) can interact with the
C/EBP-homologous protein (CHOP). FEBS Lett. 502, 57–62.
Gachon, F., Devaux, C., Mesnard, J.M., 2002. Activation of HTLV-I transcription in the
presence of Tax is independent of the acetylation of CREB-2 (ATF-4). Virology 299,
271–278.
Gaudray, G., Gachon, F., Basbous, J., Biard-Piechaczyk, M., Devaux, C., Mesnard, J.M.,
2002. The complementary strand of HTLV-1 RNA genome encodes a bZIP
transcription factor that down-regulates the viral transcription. J. Virol. 76,
12813–12822.
Gessain, A., Vernant, J.C., Maurs, L., Gout, O., Calander, A., De Thé, G., 1985. Antibodies to
human T-lymphotropic virus type 1 in patients with tropical spastic paraparesis.
Lancet 2, 407–410.
Hivin, P., Frédéric, M., Arpin-André, C., Basbous, J., Gay, B., Thébault, S., Mesnard, J.M.,
2005. Nuclear localization of HTLV-I bZIP factor (HBZ) is mediated by three distinct
motifs. J. Cell. Sci. 118, 1355–1362.
Hivin, P., Arpin-André, C., Clerc, I., Barbeau, B., Mesnard, J.M., 2006. A modiﬁed version
of a Fos-associated cluster in HBZ affects Jun transcriptional potency. Nucleic Acids
Res. 34, 2761–2772.
Hivin, P., Basbous, J., Raymond, F., Henaff, D., Arpin-Andre, C., Robert-Hebmann, V.,
Barbeau, B., Mesnard, J.M., 2007. The HBZ-SP1 isoform of human T-cell leukemia
virus type I represses JunB activity by sequestration into nuclear bodies.
Retrovirology 4, 14.Hooper, W.C., Rudolph, D.L., Lairmore, M.D., Lal, R.B., 1991. Constitutive expression of c-
Jun and Jun-B in cell lines infected with human T-lymphotropic virus types I and II.
Biochem. Biophys. Res. Commun. 181, 976–980.
Isono, O., Ohshima, T., Saeki, Y., Matsumoto, J., Hijikata, M., Tanaka, K., Shimotohno, K.,
2008. Human T-cell leukemia virus type 1 HBZ protein bypasses the targeting
function of ubiquitination. J. Biol. Chem. 283, 34273–34282.
Iwai, K., Mori, N., Oie, M., Yamamoto, N., Fujii, M., 2001. Human T-cell leukemia virus
type 1 Tax protein activates transcription through AP-1 site by inducing DNA
binding activity in T cells. Virology 279, 38–46.
Johnson, P.F., 1993. Identiﬁcation of C/EBP basic region residues involved in DNA
sequence recognition and half-site spacing preference. Mol. Cell. Biol. 13,
6919–6930.
Kashanchi, F., Brady, J.N., 2005. Transcriptional and post-transcriptional gene regulation
of HTLV-1. Oncogene 24, 5938–5951.
Kouzarides, T., Ziff, E., 1988. The role of the leucine zipper in the fos–jun interaction.
Nature 15, 646–651.
Kuhlmann, A.S., Villaudy, J., Gazzolo, L., Castellazzi, M., Mesnard, J.M., Duc Dodon, M.,
2007. HTLV-1 HBZ cooperates with JunD to enhance transcription of the human
telomerase reverse transcriptase gene (hTERT). Retrovirology 4, 92.
Landry, S., Halin, M., Vargas, A., Lemasson, I., Mesnard, J.M., Barbeau, B., 2009.
Upregulation of human T-cell leukemia virus type 1 antisense transcription by the
viral tax protein. J. Virol. 83, 2048–2054.
Larocca, D., Chao, L.A., Seto, M.H., Brunck, T.K., 1989. Human T-cell leukemia virus minus
strand transcription in infected T-cells. Bioch. Biophys. Res. Comm. 163, 1006–1013.
Lemasson, I., Polakowski, N.J., Laybourn, P.J., Nyborg, J.K., 2002. Transcription factor
binding and histone modiﬁcations on the integrated proviral promoter in HTLV-I-
infected T cells. J. Biol. Chem. 277, 49459–49465.
Lemasson, I., Lewis, M.R., Polakowski, N., Hivin, P., Cavanagh, M.H., Thebault, S., Barbeau,
B., Nyborg, J.K., Mesnard, J.M., 2007. Human T-cell leukemia virus type 1 (HTLV-1)
bZIP protein interacts with the cellular transcription factor CREB to inhibit HTLV-1
transcription. J. Virol. 81, 1543–1553.
Matsumoto, J., Ohshima, T., Isono, O., Shimotohno, K., 2005. HTLV-1 HBZ suppresses AP-
1 activity by impairing both the DNA-binding ability and the stability of c-Jun
protein. Oncogene 24, 1001–1010.
Matsuoka, M., Jeang, K.T., 2007. Human T-cell leukaemia virus type 1 (HTLV-1)
infectivity and cellular transformation. Nat. Rev. Cancer 7, 270–280.
Mesnard, J.M., Barbeau, B., Devaux, C., 2006. HBZ, a new important player in themystery
of Adult-T-cell leukemia. Blood 108, 3979–3982.
Miller, J.H., 1972. Experiments in Molecular Genetics. Cold Spring Harbor Laboratory
Cold Spring Harbor, NY.
Mori, N., Fujii, M., Iwai, K., Ikeda, S., Yamasaki, Y., Hata, T., Yamada, Y., Tanaka, Y.,
Tomonaga, M., Yamamoto, N., 2000. Constitutive activation of transcription factor
AP-1 in primary adult T-cell leukemia cells. Blood 95, 3915–3921.
Murata, K., Hayashibara, T., Sugahara, K., Uemura, A., Yamaguchi, T., Harasawa, H.,
Hasegawa, H., Tsuruda, K., Okazaki, T., Koji, T., Miyanishi, T., Yamada, Y., Kamihira,
S., 2006. A novel alternative splicing isoform of human T-cell leukemia virus type 1
bZIP factor (HBZ-SI) targets distinct subnuclear localization. J. Virol. 80,
2495–2505.
Neuberg, M., Schuermann, M., Müller, R., 1991. Mutagenesis of the DNA contact site in
Fos protein: compatibility with the scissors grip model and requirement for
transformation. Oncogene 6, 1325–1333.
Osame, M., Usuku, K., Izumo, S., Ijichi, N., Amitani, H., Igata, A., Matsumoto, J., Tara, M.,
1986. HTLV-I associated myelopathy, a new clinical entity. Lancet 1, 1031–1032.
Peloponese, J.-M., Jeang, K.-T., 2006. Role for Akt/protein kinase B and AP-1 in cellular
proliferation induced by the human T-cell leukemia virus type 1 (HTLV-1) Tax
oncoprotein. J. Biol. Chem. 281, 8927–8938.
Renard, P., Ernest, I., Houbion, A., Art, M., Le Calvez, H., Raes, M., Remacle, J., 2001.
Development of a sensitive multi-well colorimetric assay for active NFκB. Nucleic
Acids Res. 29 (4), E21.
Ryseck, R.-P., Bravo, R., 1991. c-JUN, JUN B, and JUN D differ in their binding afﬁnities to
AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 6, 533–542.
Satou, Y., Yasunaga, J.-I., Yoshida, M., Matsuoka, M., 2006. HTLV-I basic leucine zipper
factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl.
Acad. Sci. U.S.A. 103, 720–725.
Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K., Uchino, H., 1977. Adult T-cell leukemia:
clinical and hematologic features of 16 cases. Blood 50, 481–492.
Usui, T., Yanagihara, K., Tsukasaki, K., Murata, K., Hasegawa, H., Yamada, Y., Kamihira, S.,
2008. Characteristic expression of HTLV-1 basic zipper factor (HBZ) transcripts in
HTLV-1 provirus-positive cells. Retrovirology 5, 34.
Vinson, C.R., Sigler, P.B., McKnight, S.L., 1989. Scissors-grip model for DNA recognition by
a family of leucine zipper proteins. Science 246, 911–916.
Wurch, T., Kirchherr, D., Mesnard, J.-M., Lebeurier, G., 1990. The cauliﬂower mosaic virus
open reading frame VII product can be expressed in Saccharomyces cerevisiae but is
not detected in infected plants. J. Virol. 64, 2594–2598.
Yoshida, M., Satou, Y., Yasunaga, J., Fujisawa, J.-I., Matsuoka, M., 2008. Transcriptional
control of spliced and unspliced HTLV-1 bZIP factor gene. J. Virol. 82, 9359–9368.
